Amkor Technology enters the final stretch before its October 26 earnings with a cluster of signals pulling in different directions: a family-controlled activist register, a string of insider sales by directors, short interest that ticked up 7% on the week, and a stock that has still gained 13% over the past month.
The ownership picture is the place to start. John T. Kim holds a Schedule 13D position covering roughly 30.4% of Amkor's outstanding shares, filing the most recent amendment in May 2026. A 13D is an activist-intent filing, not a passive stake, and at nearly a third of the company it is the single most structurally important fact about this register. The Kim family more broadly, through a network of trusts and personal holdings, controls a majority of the float-adjusted position. That concentration means most of the trading action is happening in a relatively thin slice of freely available shares. Separately, the SEC's 13D/G register shows Vanguard's most recent filing carries a 0% position, suggesting they exited below the 5% disclosure threshold without a further filing, the standard caveat applies: stakes are as-last-disclosed.
The more pointed ownership signal this week comes from insiders selling. Director Guillaume Rutten sold 50,000 shares across two days in early August at prices between $54.50 and $55.35, totalling just over $2.7 million. Those sales were not under a pre-arranged 10b5-1 plan, which makes them more discretionary than the CFO and General Counsel sales that followed, all of which were plan-driven. The CEO also sold around 3,200 shares at $47 in late July, shortly after the Q2 print. Net, insiders have sold roughly $4 million worth of stock over the past 90 days on a net basis. None of the sales are individually alarming given the stock's strong run, but the absence of any open-market buying alongside a director making a seven-figure unplanned exit is worth noting with Q3 results four weeks out.
Short positioning is modest but building. Short interest has climbed to about 3.98% of the free float, up 7.3% on the week from roughly 9.2 million to 9.8 million shares. That is a meaningful one-week step-up even if the absolute level remains low. Importantly, the borrow market is not under any stress: availability is extremely loose, with shares available to borrow running at over eleven times current short interest. Cost to borrow is barely above zero at 0.46%, effectively unchanged on the month. The shorts adding this week are doing so cheaply and easily, which rules out a supply-driven squeeze as a near-term catalyst. ORTEX's short score of 46 places Amkor at the lower-to-mid range of bearish conviction across the universe, consistent with a position that reflects caution rather than conviction.
Options positioning is similarly measured. The put/call ratio is 0.73, slightly above its 20-day average of 0.71 and less than one standard deviation from the mean. The 52-week range runs from 0.09 to 1.15, so the current reading sits nowhere near the defensive extremes the market has reached on this name before. If options traders were seriously concerned about the Q3 print, the PCR would look more stretched. The absence of a defensive bid is notable given that the last earnings, on July 27, produced a one-day decline of nearly 30% and a five-day drop of almost 22%. The stock has recovered substantially since, climbing 13% over the past month to $54.14, but options traders do not appear to be paying up for protection at this level.
The Street sits broadly constructive. Five analysts carry buy ratings against no sells, with a consensus mean target of $76.40, implying roughly 41% upside from the current price. BofA Securities initiated coverage with a Buy in late August at a $70 target, while Morgan Stanley lifted its Equal-Weight target to $70 shortly after the July results. Needham and UBS both hold $90 targets. Goldman Sachs remains at Neutral but raised its target sharply to $65 from $43 after the Q1 print. The split is clear: the bulls are anchored to Amkor's positioning in advanced packaging, AI data centre demand, and its Arizona facility buildout. The bears, or more precisely the neutrals, flag PC market softness, foreign revenue concentration, and the fact that the stock is trading well below the more optimistic targets even after last month's rally. Valuation has expanded: the P/E has moved up by around 2.4 points over the past 30 days to just under 20x, and price-to-book is at 2.47x, both reflective of a stock that has re-rated on sector sentiment rather than a fresh earnings beat.
Among closely correlated peers, FORM gained 8.1% on the week and ONTO added 7.4%, both outpacing Amkor's slight weekly dip of 0.8%. ENTG, COHU and LRCX all posted modest gains of 2 to 4%. The underperformance on the week is a minor reversal after a strong September for Amkor, and the peer group's broad strength suggests semiconductor equipment sentiment is not the headwind. The October 26 Q3 print is therefore less about whether sector demand is holding up and more about whether management can reframe the narrative after a quarter that saw the stock fall nearly a third in a single session.
See the live data behind this article on ORTEX.
Open AMKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
